TW201632627A - Method for producing fermented and aged placenta solution - Google Patents

Method for producing fermented and aged placenta solution Download PDF

Info

Publication number
TW201632627A
TW201632627A TW104137012A TW104137012A TW201632627A TW 201632627 A TW201632627 A TW 201632627A TW 104137012 A TW104137012 A TW 104137012A TW 104137012 A TW104137012 A TW 104137012A TW 201632627 A TW201632627 A TW 201632627A
Authority
TW
Taiwan
Prior art keywords
solution
placenta
amino acid
producing
fermented
Prior art date
Application number
TW104137012A
Other languages
Chinese (zh)
Other versions
TWI633189B (en
Inventor
Yukio Mitsui
Original Assignee
Horus Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horus Co Ltd filed Critical Horus Co Ltd
Publication of TW201632627A publication Critical patent/TW201632627A/en
Application granted granted Critical
Publication of TWI633189B publication Critical patent/TWI633189B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L13/00Meat products; Meat meal; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L13/00Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/20Meat products; Meat meal; Preparation or treatment thereof from offal, e.g. rinds, skins, marrow, tripes, feet, ears or snouts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982Reproductive organs; Embryos, Eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A method for producing a fermented and aged placenta solution according to the present invention comprises adding yeast cells having a fermentation activity to a porcine, sheep or horse placenta solution and then fermenting and aging the placenta, wherein brown sugar is added in an amount of 6 to 15% by weight relative to the weight of the placenta solution to the placenta solution to ferment the placenta solution, and the solution is aged after the fermentation. Thus, it becomes possible to provide a method for producing a fermented and aged placenta solution, in which the absorbability of the placenta solution can be improved and the amount of an effective ingredient in the solution can be increased.

Description

發酵熟成胎盤溶液的製造方法 Method for producing fermented mature placenta solution

本發明係關於利用為健康食品用原料或化妝品用原料之發酵熟成胎盤溶液的製造方法。 The present invention relates to a method for producing a fermented cooked placenta solution using a raw material for a health food or a raw material for cosmetics.

在萃取自屬於哺乳動物獨有的臟器之胎盤(placenta)的胎盤素中,係包含胺基酸或酵素類等各式各樣的有用成分。因此,胎盤素現正用作健康食品或化妝品之原料等,而在其中,特別是從安全性之方面而言,大多使用萃取自豬或羊、馬之胎盤的胎盤素。 In the placenta which extracts a placenta which is unique to a mammal, it contains various useful components such as an amino acid or an enzyme. Therefore, placenta is now being used as a raw material for health foods or cosmetics, and among them, in particular, from the aspect of safety, placenta extracted from a placenta of pigs or sheep and horses is mostly used.

此處,在專利文獻1中,已提案一種含有豬的胎盤之健康食品的製造方法,其係將豬的胎盤以水分成為50%(重量)至80%(重量)之方式進行煮沸後,加入包含具有發酵作用之酵母菌及乳酸菌之發酵液,在發酵前或發酵途中加入葡萄糖並使其於20℃至35℃發酵24小時至72小時。 Here, Patent Document 1 proposes a method for producing a health food containing a placenta of pigs, which is obtained by boiling the placenta of the pig so as to have a moisture content of 50% by weight to 80% by weight. A fermentation broth containing a fermentation yeast and a lactic acid bacterium, glucose is added before fermentation or during fermentation, and fermentation is carried out at 20 ° C to 35 ° C for 24 hours to 72 hours.

〔先前技術文獻〕 [Previous Technical Literature] 〔專利文獻〕 [Patent Document]

[專利文獻1]日本專利特開2005-185242號公報 [Patent Document 1] Japanese Patent Laid-Open Publication No. 2005-185242

然而,在用作健康食品或化妝品等之原料之情況,係期望使胎盤溶液的吸收性或有用成分盡可能地增加,但如專利文獻1所記載之發明般,僅在煮沸後使其發酵24小時至72小時,就使胎盤溶液的吸收性或有用成分增加而言並不充分。 However, when it is used as a raw material of a health food or a cosmetic, it is desirable to increase the absorbability or useful component of the placental solution as much as possible. However, as in the invention described in Patent Document 1, the fermentation is carried out only after boiling. From hour to 72 hours, the absorption or useful component of the placental solution is not sufficient.

於是,本發明之目的係提供使胎盤溶液的吸收性或有用成分增加之發酵熟成胎盤溶液的製造方法。 Accordingly, it is an object of the present invention to provide a method of producing a fermented cooked placenta solution that increases the absorbency or useful components of a placental solution.

請求項1所記載之本發明之發酵熟成胎盤溶液的製造方法,係在豬、羊或馬的胎盤溶液中,加入具有發酵作用之酵母菌而使胎盤發酵及熟成之發酵熟成胎盤溶液的製造方法,其特徵為將相對於胎盤溶液而言以重量比計6~15%的黑糖添加至胎盤溶液中並使其發酵,並在發酵後使其熟成。 The method for producing a fermented mature placenta solution of the present invention according to claim 1, which is a method for producing a placenta solution by fermenting fermented yeast and fermenting the placenta into a placenta solution of pig, sheep or horse It is characterized in that 6 to 15% by weight of brown sugar is added to the placenta solution relative to the placental solution and fermented, and then matured after fermentation.

請求項2所記載之本發明,其特徵為在請求項1所記載之發酵熟成胎盤溶液的製造方法中,具有下列步驟:將黑糖添加至胎盤溶液中之黑糖添加步驟;在黑糖添加步驟之後,於80~100℃的溫度中進行20分鐘~60分鐘加熱殺菌之殺菌步驟;在殺菌步驟之後,強制冷卻至35℃以 下的溫度之冷卻步驟;在冷卻步驟之後,加入酵母菌並於20℃~35℃的溫度中使其發酵1個月之發酵步驟;以及在發酵步驟之後,於20℃~25℃的溫度中使其熟成2個月之熟成步驟。 The present invention according to claim 2, characterized in that in the method for producing a fermented cooked placenta solution according to claim 1, the method comprises the steps of: adding a brown sugar to a brown sugar addition step in a placental solution; after the brown sugar adding step, a sterilization step of heat sterilization at a temperature of 80 to 100 ° C for 20 minutes to 60 minutes; after the sterilization step, forced cooling to 35 ° C a cooling step of the lower temperature; after the cooling step, the yeast is added and fermented at a temperature of 20 ° C to 35 ° C for one month; and after the fermentation step, at a temperature of 20 ° C to 25 ° C Make it ripe for 2 months of ripening.

請求項3所記載之本發明,其特徵為在請求項2所記載之發酵熟成胎盤溶液的製造方法中,在熟成結束後所測定之S-腺苷甲硫胺酸(SAMe)及超活性胺基酸(SA胺基酸)的濃度係將相對於胎盤溶液而言以重量比計10%的蔗糖代替黑糖添加至胎盤溶液中並施行殺菌步驟至熟成步驟所產生之SAMe及SA胺基酸的濃度以上。 The present invention according to claim 3 is characterized in that, in the method for producing a fermented mature placenta solution according to claim 2, S-adenosylmethionine (SAMe) and super-active amine are measured after completion of the ripening. The concentration of the base acid (SA amino acid) is such that 10% by weight of sucrose is added to the placenta solution relative to the placental solution, and the sterilization step is performed to the SAMe and SA amino acid produced by the ripening step. Above the concentration.

請求項4所記載之本發明,其特徵為在請求項2所記載之發酵熟成胎盤溶液的製造方法中,在熟成結束後所測定之SAMe及SA胺基酸的濃度係將相對於胎盤溶液而言以重量比計10%的葡萄糖代替黑糖添加至胎盤溶液中並施行殺菌步驟至熟成步驟所產生之SAMe及SA胺基酸的濃度以上。 According to the invention of claim 4, in the method for producing a fermented mature placenta solution according to claim 2, the concentration of the SAMe and the SA amino acid measured after completion of the aging is relative to the placental solution. 10% by weight of glucose is added to the placenta solution instead of brown sugar and the sterilization step is performed until the concentration of SAMe and SA amino acid produced by the ripening step is above.

請求項5所記載之本發明,其特徵為在請求項2至請求項4中任一項所記載之發酵熟成胎盤溶液的製造方法中,在熟成步驟之後的固形份中所計測之分子量分佈係就未滿200而言為10~20%、就1000~3000而言為30~40%、就3000~6000而言為20~25%。 The present invention described in claim 5, wherein the molecular weight distribution measured in the solid portion after the ripening step is a method for producing a fermented mature placenta solution according to any one of claims 2 to 4. It is 10 to 20% for less than 200, 30 to 40% for 1000 to 3000, and 20 to 25% for 3000 to 6000.

請求項6所記載之本發明,其特徵為在請求項2至請求項4中任一項所記載之發酵熟成胎盤溶液的製造方法中,在熟成步驟之後的固形份中,係包含丙胺酸10莫耳 %以上、胱胺酸0.4莫耳%以上。 The present invention according to claim 6 is characterized in that in the method for producing a fermented cooked placenta solution according to any one of claims 2 to 4, the solid portion after the ripening step contains alanine 10 Moer More than %, cystine acid 0.4% or more.

請求項7所記載之本發明,其特徵為在請求項2至請求項4中任一項所記載之發酵熟成胎盤溶液的製造方法中,在熟成步驟之後的固形份中,係包含鈉300mg/100g以上、鈣100mg/100g以上、鎂15mg/100g以上、菸鹼酸2mg/100g以上、鋅2mg/100g以上。 The present invention according to claim 7 is characterized in that, in the method for producing a fermented cooked placenta solution according to any one of claims 2 to 4, the solid portion after the ripening step contains sodium 300 mg/ 100 g or more, calcium 100 mg/100 g or more, magnesium 15 mg/100 g or more, nicotinic acid 2 mg/100 g or more, and zinc 2 mg/100 g or more.

根據本發明,可獲得可使吸收性增高並使有用成分增加,且經由摻合於化妝品中而提升保濕力,經由摻合於健康食品中而成為溫和的味道之胎盤素。 According to the present invention, it is possible to obtain a placenta which can increase the absorbability and increase the useful component, and enhances the moisturizing power by blending into a cosmetic product, and becomes a mild taste by blending into a healthy food.

圖1係顯示SA胺基酸之活性氧去除作用之圖。 Figure 1 is a graph showing the removal of active oxygen from the SA amino acid.

圖2係顯示SA胺基酸之過氧化脂質的抑制作用之圖。 Fig. 2 is a graph showing the inhibitory effect of peroxidase of the SA amino acid.

圖3係顯示塗佈摻合SA胺基酸之化妝品後之肌膚的角質水分量之推移之圖。 Fig. 3 is a graph showing the transition of the horny moisture content of the skin after application of the cosmetic containing the SA amino acid.

圖4係顯示塗佈摻合SA胺基酸之化妝品後之肌膚的經表皮水分蒸散量之推移之圖。 Fig. 4 is a graph showing the transition of the transepidermal water evapotranspiration of the skin after application of the SA amino acid-incorporated cosmetic.

圖5係顯示SA胺基酸之MMP-1活性抑制作用之圖。 Fig. 5 is a graph showing the inhibition of MMP-1 activity of the SA amino acid.

圖6係對添加相對於胎盤溶液而言以重量比計3%、 6%、10%、15%的黑糖,在熟成結束後所測定之SAMe及SA胺基酸的產生進行比較之圖。 Figure 6 is a ratio of 3% by weight relative to the placental solution. The comparison of the production of SAMe and SA amino acid measured at 6%, 10%, and 15% of brown sugar after completion of ripening.

圖7係顯示在使黑糖對胎盤溶液之添加時機不同之實驗中,在熟成結束後所測定之SAMe產生及SA胺基酸產生之結果之圖。 Fig. 7 is a graph showing the results of SAMe production and SA amino acid production measured after the completion of the ripening in an experiment in which the timing of adding the brown sugar to the placental solution was different.

圖8係顯示在使發酵期不同之實驗中,SAMe產生及SA胺基酸產生之測定結果之圖。 Fig. 8 is a graph showing the results of measurement of SAMe production and SA amino acid production in experiments in which fermentation periods were different.

圖9係顯示在使熟成期不同之實驗中,SAMe產生及SA胺基酸產生之測定結果之圖。 Fig. 9 is a graph showing the results of measurement of SAMe production and SA amino acid production in experiments in which the ripening period was different.

圖10係顯示依據本發明之一實施例之發酵熟成胎盤之分子量分佈之圖。 Figure 10 is a graph showing the molecular weight distribution of a fermented mature placenta according to an embodiment of the present invention.

圖11係顯示相同發酵熟成胎盤之成分之圖。 Figure 11 is a graph showing the composition of the same fermented mature placenta.

圖12係顯示相同發酵熟成胎盤之礦物質/維生素含量之圖。 Figure 12 is a graph showing the mineral/vitamin content of the same fermented mature placenta.

依據本發明之第1實施形態之發酵熟成胎盤溶液的製造方法係將相對於胎盤溶液而言以重量比計6~15%的黑糖添加至胎盤溶液中並使其發酵,並在發酵後使其熟成。根據本實施形態,可獲得可使吸收性增高並使有用成分增加,且經由摻合於化妝品中而提升保濕力,經由摻合於健康食品中而成為溫和的味道之胎盤。 According to the method for producing a fermented cooked placenta solution according to the first embodiment of the present invention, 6 to 15% by weight of brown sugar is added to the placental solution with respect to the placental solution, and fermented, and after fermentation, ripe. According to the present embodiment, it is possible to obtain a placenta which can increase the absorbability and increase the useful component, and enhance the moisturizing power by blending in the cosmetic product, thereby becoming a mild taste by blending into the health food.

本發明之第2實施形態係在依據第1實施形態之發酵熟成胎盤溶液的製造方法中,具有下列步驟:將 黑糖添加至胎盤溶液中之黑糖添加步驟;在黑糖添加步驟之後,於80~100℃的溫度中進行20分鐘~60分鐘加熱殺菌之殺菌步驟;在殺菌步驟之後,強制冷卻至35℃以下的溫度之冷卻步驟;在冷卻步驟之後,加入酵母菌並於20℃~35℃的溫度中使其發酵1個月之發酵步驟;以及在發酵步驟之後,於20℃~25℃的溫度中使其熟成2個月之熟成步驟。根據本實施形態,可特別提高SAMe及SA胺基酸的濃度。 According to a second aspect of the present invention, in the method for producing a fermented cooked placenta solution according to the first embodiment, the method has the following steps: Brown sugar is added to the brown sugar addition step in the placenta solution; after the brown sugar addition step, the sterilization step of heat sterilization is performed at a temperature of 80 to 100 ° C for 20 minutes to 60 minutes; after the sterilization step, forced cooling to a temperature below 35 ° C a cooling step; after the cooling step, the yeast is added and fermented at a temperature of 20 ° C to 35 ° C for one month; and after the fermentation step, it is aged at a temperature of 20 ° C to 25 ° C 2 months of ripening steps. According to this embodiment, the concentration of SAMe and SA amino acid can be particularly increased.

此處,SAMe係指S-腺苷甲硫胺酸(S-adenosylmethionine),SA胺基酸係指超活性胺基酸(super active amino acid)。 Here, SAMe means S-adenosylmethionine, and SA-amino acid means super active amino acid.

SAMe(S-腺苷甲硫胺酸)係於1974年歐洲在世界上最初被開發為憂鬱症之治療藥。此外,在美國係作為對關節炎特別有效果之補充品而受到歡迎,除了關節炎以外,亦被認為對憂鬱症、肝疾患有效果。特定而言,關節症的患者係呈逐年增加之傾向,支撐關節之健康食品等的需求係逐漸提高。 SAMe (S-adenosylmethionine) was first developed in Europe in 1974 as a therapeutic drug for depression. In addition, it is popular in the United States as a supplement to arthritis, and it is considered to have an effect on depression and liver disease in addition to arthritis. In particular, the number of patients with joint disease tends to increase year by year, and the demand for healthy foods that support joints is gradually increasing.

此外,SA胺基酸(超活性胺基酸)係具有3項作用之胺基酸。 Further, the SA amino acid (superactive amino acid) is an amino acid having three functions.

第1項為活性氧抑制效果。由於活性氧係構造上不安定,因而會與皮膚的DNA或脂質、蛋白質結合而引起細胞傷害,成為皮膚老化之一項原因。 The first item is the active oxygen inhibition effect. Since the active oxygen system is structurally unstable, it binds to DNA or lipids and proteins of the skin and causes cell damage, which is a cause of skin aging.

圖1係藉由測定利用次黃嘌呤-黃嘌呤氧化酶系統使O2 -生成,並使SA胺基酸共存時之O2 -生成量,而顯示出 SA胺基酸之活性氧去除作用。O2 -係使用作為顯色試藥之硝基藍四唑鎓(nitroblue tetrazolium)進行檢測。此處,SA胺基酸係顯示出濃度依存性地消去O2 -Figure 1 is measured by using hypoxanthine - xanthine oxidase system enables the O 2 - generation, when the O and amino acids coexist SA 2 - generation amount, SA exhibit active oxygen removal effect of the amino acid. O 2 - was detected using nitroblue tetrazolium as a color reagent. Here, the SA amino acid system shows a concentration-dependent elimination of O 2 - .

此外,圖2係顯示SA胺基酸對於以使用阿脲(alloxan)而化學性產生之O2 -作為起始劑之脂質過氧化反應的抑制作用之圖。另外,已知阿脲會化學性生成O2 -,並給予氧化壓力。此處,SA胺基酸相較於其他抗氧化劑而言係顯示出顯著地抑制脂質的氧化。 Further, Fig. 2 is a graph showing the inhibitory effect of the SA amino acid on the lipid peroxidation reaction using O 2 - which is chemically produced using alloxan as a starter. In addition, it is known that alloxan chemically generates O 2 - and gives oxidative stress. Here, the SA amino acid phase shows a significant inhibition of lipid oxidation compared to other antioxidants.

第2項為保濕效果。圖3、4係顯示以角質水分量呈現低值,並有肌膚粗糙/乾燥等自覺之40~60歲的成人女性7名(平均年齡47.1歲)為對象,實施開放性試驗之結果,圖3係顯示塗佈摻合SA胺基酸之化妝品後之肌膚的角質水分量〔μS〕之推移之圖,圖4係顯示塗佈摻合SA胺基酸之化妝品後之肌膚的經表皮水分蒸散量〔g/m2.h〕之推移之圖。將試驗期設為8週,在早晚2次每次洗淨後適量塗佈含有SA胺基酸之製品。在試驗開始日及自試驗開始起4、8週後測定肌膚的角質水分量及經表皮水分蒸散量,並施行評估。此處,藉由8週的連用,角質水分量在含有SA胺基酸之製品連用部位,係明顯地上升。此可視為角質的水分保持機能本身獲得改善之結果。針對經表皮水分蒸散量,亦可看出降低之傾向,並可認出乾燥狀態的改善。 The second item is moisturizing effect. Fig. 3 and Fig. 3 show the results of an open-label test in which 7 female adults (aged age 47.1 years old) aged 40 to 60 years old, who have a low value of keratinous water and have a rough skin/dryness, are shown. The figure shows the transition of the keratinous water content (μS) of the skin after application of the cosmetic containing the SA amino acid, and FIG. 4 shows the transepidermal water evapotranspiration of the skin after the application of the cosmetic containing the SA amino acid. [g/m 2 . h] The map of the transition. The test period was set to 8 weeks, and a product containing SA amino acid was applied in an appropriate amount after washing twice in the morning and evening. The skin keratinous water content and transepidermal water evapotranspiration were measured at the start of the test and 4 and 8 weeks after the start of the test, and evaluation was performed. Here, by the use of 8 weeks of continuous use, the amount of keratinous water is significantly increased in the joint portion of the product containing the SA amino acid. This can be seen as an improvement in the keratinous moisture retention function itself. For the amount of transepidermal water evapotranspiration, the tendency to decrease can also be seen, and the improvement of the dry state can be recognized.

第3項為膠原蛋白產生效果。作為分解I型膠原蛋白之酵素之MMP-1係藉由暴露於UVA(紫外線A波)而活 化。圖5係為了評估SA胺基酸之MMP-1活性阻礙,而實際驗證藉由UVA所亢進之MMP-1的活性是否會受到SA胺基酸所抑制之結果。對於正常人類纖維母細胞,使各種濃度的SA胺基酸共存並照射UVA,在24小時後回收培養基,並測定其MMP-1活性。由此,SA胺基酸係顯示出濃度依存性地抑制MMP-1的活性。 The third item is the collagen production effect. MMP-1, an enzyme that breaks down type I collagen, lives by exposure to UVA (ultraviolet A wave) Chemical. Figure 5 is a graph showing whether the activity of MMP-1 which is amplified by UVA is inhibited by the SA amino acid in order to evaluate the inhibition of MMP-1 activity of the SA amino acid. For normal human fibroblasts, various concentrations of SA amino acid were allowed to coexist and irradiated with UVA, and the medium was recovered after 24 hours, and its MMP-1 activity was measured. Thus, the SA amino acid system showed a concentration-dependent inhibition of the activity of MMP-1.

根據依據本實施形態之發酵熟成胎盤溶液的製造方法,可獲得在熟成結束後所測定之SAMe及SA胺基酸的濃度係將相對於胎盤溶液而言以重量比計10%的蔗糖代替黑糖添加至胎盤溶液中並施行殺菌步驟至熟成步驟所產生之SAMe及SA胺基酸的濃度以上之胎盤溶液。 According to the method for producing a fermented mature placenta solution according to the present embodiment, it is possible to obtain a concentration of SAMe and SA amino acid measured after the completion of the ripening, and to add 10% by weight of sucrose to the brown sugar instead of the placental solution. The placental solution is applied to the placental solution and subjected to a sterilization step to a concentration of SAMe and SA amino acid produced by the ripening step.

根據依據本實施形態之發酵熟成胎盤溶液的製造方法,可獲得在熟成結束後所測定之SAMe及SA胺基酸的濃度係將相對於胎盤溶液而言以重量比計10%的葡萄糖代替黑糖添加至胎盤溶液中並施行殺菌步驟至熟成步驟所產生之SAMe及SA胺基酸的濃度以上之胎盤溶液。 According to the method for producing a fermented mature placenta solution according to the present embodiment, it is possible to obtain a concentration of SAMe and SA amino acid measured after the completion of the aging, and to add 10% by weight of glucose to the placenta solution instead of brown sugar. The placental solution is applied to the placental solution and subjected to a sterilization step to a concentration of SAMe and SA amino acid produced by the ripening step.

根據依據本實施形態之發酵熟成胎盤溶液的製造方法,可獲得在熟成步驟之後的固形份中所計測之分子量分佈係就未滿200而言為10~20%、就1000~3000而言為30~40%、就3000~6000而言為20~25%之胎盤溶液,藉由平衡良好地摻合各式各樣分子量的胺基酸或胜肽,可提高保濕效果。 According to the method for producing a fermented mature placenta solution according to the present embodiment, the molecular weight distribution measured in the solid portion after the ripening step can be 10 to 20% in the case of less than 200, and 30 to 1000 to 3000 in terms of 1000 to 3000. ~40%, 20~25% placenta solution for 3000~6000, the moisturizing effect can be improved by blending well with various amino acid amino acids or peptides.

根據依據本實施形態之發酵熟成胎盤溶液的製造方法,在熟成步驟之後的固形份中,係包含丙胺酸 10莫耳%以上、胱胺酸0.4莫耳%以上。 According to the method for producing a fermented mature placenta solution according to the present embodiment, the adipic acid is contained in the solid portion after the ripening step. 10 mol% or more, cystine acid 0.4 mol% or more.

丙胺酸及胱胺酸係會對人體給予有效影響之胺基酸之一。丙胺酸係大量包含在蜆或蛤等貝類中之胺基酸,除了肝機能的改善以外,尚作為使免疫機能提升之胺基酸而包含在許多健康食品中。胱胺酸係2分子半胱胺酸鍵結而成之胺基酸,其係作為構成稱為角蛋白的蛋白質之胺基酸而大量含在毛髮或指甲中。就美白效果而言,由於其具有抑制會生成黑色的黑色素之酪胺酸酶的活性之作用,因而係大量摻合於化妝品等中。 Alanine and cystine are one of the amino acids that have an effective effect on the human body. Alanine is an amino acid which is contained in a large amount in shellfish such as sputum or sputum. In addition to the improvement of liver function, it is included in many health foods as an amino acid which enhances immune function. The cysteic acid is an amino acid in which two molecules of cysteine are bonded, and is contained in a large amount in the hair or nail as an amino acid constituting a protein called keratin. In terms of the whitening effect, since it has an action of inhibiting the activity of tyrosinase which produces black melanin, it is incorporated in a large amount in cosmetics or the like.

根據依據本實施形態之發酵熟成胎盤溶液的製造方法,在熟成步驟之後的固形份中,係包含鈉300mg/100g以上、鈣100mg/100g以上、鎂15mg/100g以上、菸鹼酸2mg/100g以上、鋅2mg/100g以上。 According to the method for producing a fermented mature placenta solution according to the present embodiment, the solid content after the ripening step includes sodium 300 mg/100 g or more, calcium 100 mg/100 g or more, magnesium 15 mg/100 g or more, and nicotinic acid 2 mg/100 g or more. , zinc 2mg/100g or more.

此等礦物質近年來係呈攝取量降低之傾向。舉例而言,鉀係呈現出在飲食攝取基準2015年版中所設定之成人攝取目標之約1~2成左右強係不足之問卷調查結果。特定而言,鋅在20~60世代中之不足係顯著,若基於飲食攝取基準所設定之建議量進行比較,則男女皆低於約1成。鎂係15歲以上的年齡層不夠充足,在20世代中可謂近3成係不足。由於此等礦物質之不足,除了女性的低體重化或骨質疏鬆症以外,尚有糖尿病的感染風險亦提高之傾向。因此,礦物質的攝取對於現代人而言可謂重大課題之一。 These minerals have been in a tendency to decrease in intake in recent years. For example, the potassium system presents a questionnaire survey result of about 1 to 20% of the adult intake target set in the 2015 edition of the dietary intake standard. In particular, the deficiency of zinc in the 20th to 60th generations is significant, and if the comparison is based on the recommended amount set by the dietary intake criteria, both men and women are less than about 10%. Magnesium is not enough in the age group of 15 years old or older. In the 20th generation, nearly 30% of the system is insufficient. Due to the shortage of these minerals, in addition to low body weight or osteoporosis in women, there is a tendency for the risk of diabetes infection to increase. Therefore, the intake of minerals is one of the major issues for modern people.

〔實施例〕 [Examples]

以下係針對依據本發明之一實施例之發酵熟成胎盤溶液的製造方法進行說明。 Hereinafter, a method for producing a fermented cooked placenta solution according to an embodiment of the present invention will be described.

依據本實施例之發酵熟成胎盤溶液係具有下列步驟:將黑糖添加至胎盤溶液中之黑糖添加步驟;在黑糖添加步驟之後,於80~100℃的溫度中進行20分鐘~60分鐘加熱殺菌之殺菌步驟;在殺菌步驟之後,強制冷卻至35℃以下的溫度之冷卻步驟;在冷卻步驟之後,加入酵母菌並於20℃~35℃的溫度中使其發酵1個月之發酵步驟;以及在發酵步驟之後,於20℃~25℃的溫度中使其熟成2個月之熟成步驟。 The fermented mature placenta solution according to the present embodiment has the following steps: adding brown sugar to the brown sugar adding step in the placenta solution; after the brown sugar adding step, performing sterilization sterilization at a temperature of 80 to 100 ° C for 20 minutes to 60 minutes a step of cooling after forced to a temperature of 35 ° C or lower after the sterilization step; after the cooling step, the yeast is added and fermented at a temperature of 20 ° C to 35 ° C for one month; and in the fermentation After the step, the mixture is aged for 2 months at a temperature of 20 ° C to 25 ° C.

胎盤素粉末係自豬、羊或馬的胎盤(placenta)去除皮膜組織,將絨毛組織切碎,以凍結酵素萃取法萃取出萃取物,並自此萃取物進一步去除雜質而成者,相對於胎盤而言以重量%計係8%左右。 The placenta powder is obtained by removing the film tissue from the placenta of the pig, sheep or horse, chopping the villus tissue, extracting the extract by the frozen enzyme extraction method, and further extracting the impurities from the extract, relative to the placenta In terms of % by weight, it is about 8%.

此外,在具有發酵作用之酵母菌中,可使用例如酵母菌(Saccharomyces)屬、念珠菌(Candida)屬、圓酵母菌(Torulopsis)屬、接合酵母菌(Zygosaccharomyces)屬、裂殖酵母菌(Schizosaccharomyces)屬、畢赤酵母菌(Pichia)屬、漢遜酵母菌(Hansenula)屬、克魯維酵母菌(Kluyveromyces)屬、德巴利酵母菌(Debaryomyces)屬。 Further, among the yeast having fermentation action, for example, Saccharomyces, Candida, Torulopsis, Zygosaccharomyces, Schizosaccharomyces can be used. ), genus Pichia, Hansenula, Kluyveromyces, Debaryomyces.

在黑糖添加步驟中所添加之黑糖係設為相對於胎盤溶液而言以重量比計6~15%,更佳為6~10%。 The brown sugar added in the brown sugar addition step is set to be 6 to 15% by weight, more preferably 6 to 10% by weight, based on the placental solution.

圖6係添加相對於胎盤溶液而言以重量比計3%(實施例1)、6%(實施例2)、10%(實施例3)、15%(實施例4)的黑糖,測定在熟成結束後所測定之SAMe及SA胺基酸的產生,將產生最多者設為100並進行比較而得者。作為比較例,係使用相對於胎盤溶液而言以重量比計10%的蔗糖(比較例1)、及10%的葡萄糖(比較例2)。 Figure 6 shows the addition of 3% by weight (Example 1), 6% (Example 2), 10% (Example 3), 15% (Example 4) of brown sugar to the placental solution, measured in The generation of SAMe and SA amino acid measured after the completion of the ripening was obtained by setting the most to 100 and comparing them. As a comparative example, 10% by weight of sucrose (Comparative Example 1) and 10% of glucose (Comparative Example 2) with respect to the placental solution were used.

就SAMe的產生而言,6~15%的黑糖係達10%的蔗糖以上,6~10%的黑糖係高於10%的蔗糖、及10%的葡萄糖。 For the production of SAMe, 6 to 15% of the brown sugar is more than 10% of sucrose, 6 to 10% of the brown sugar is higher than 10% of sucrose, and 10% of glucose.

就SA胺基酸的產生而言,3~15%的黑糖係高於10%的蔗糖、及10%的葡萄糖,但特定而言,6~10%的黑糖係達較高濃度。 In terms of the production of SA amino acid, 3 to 15% of the brown sugar is higher than 10% of sucrose and 10% of glucose, but specifically, 6 to 10% of the brown sugar is at a higher concentration.

其次,針對黑糖之添加時機進行說明。 Next, the timing of adding brown sugar will be described.

圖7係對在發酵開始時添加100%(總量)、在發酵開始時添加80%並在發酵途中添加20%、在發酵開始時添加50%並在發酵途中添加50%、在發酵開始時添加80%並在熟成開始時添加20%、在發酵開始時添加50%並在熟成開始時添加50%之情況之SAMe及SA胺基酸的產生進行比較之實驗結果。 Figure 7 is the addition of 100% (total) at the beginning of the fermentation, 80% at the start of the fermentation and 20% during the fermentation, 50% at the start of the fermentation and 50% at the start of the fermentation, at the beginning of the fermentation. The results of the comparison were made by adding 80% of the addition of SAMe and SA amino acid at the beginning of the ripening, adding 20% at the beginning of the fermentation, and adding 50% at the beginning of the ripening.

添加相對於胎盤溶液而言以重量比計6%的黑糖,並將總量設為100而進行表示。在熟成結束後所測定之SAMe及SA胺基酸的濃度,除了在發酵開始時以外另在發酵途中或熟成開始時添加一部分之情況係全部低於僅在 發酵開始時進行添加之情況。 A black sugar of 6% by weight based on the placental solution was added, and the total amount was set to 100. The concentration of SAMe and SA amino acid measured after the completion of the ripening, except for the addition of a part of the fermentation or the start of the ripening at the start of the fermentation, is all lower than only The addition is carried out at the beginning of the fermentation.

從而,在著眼於SAMe及SA胺基酸之情況,黑糖較佳係僅在發酵開始時進行添加。 Thus, in view of the SAMe and SA amino acids, the brown sugar is preferably added only at the beginning of the fermentation.

在黑糖添加步驟之後進行加熱殺菌。加熱殺菌後,係例如在60分鐘以內,使用冷水循環裝置,冷卻至35℃以下,較佳為25℃。若在糖與胺基酸共存之狀態下過度加熱,則因糖與胺基酸會進行結合、或該等之構造會發生變化,而使得發酵熟成之效果降低,熟成後之胎盤溶液會發生變色,並對氣味造成影響。 The heat sterilization is carried out after the brown sugar addition step. After heat sterilization, it is cooled to 35 ° C or lower, preferably 25 ° C, for example, within 60 minutes using a cold water circulation device. If the sugar is excessively heated in a state in which the amino acid coexists, the sugar and the amino acid may be combined, or the structure may be changed, so that the effect of the fermented ripening is lowered, and the cooked placenta solution is discolored. And affect the odor.

其次,針對發酵步驟進行說明。 Next, the fermentation step will be described.

圖8係對使發酵期不同之情況之SAMe及SA胺基酸的產生進行比較之實驗結果。測定在熟成結束後所測定之SAMe及SA胺基酸的產生,將產生最多者設為100並進行比較。另外,發酵溫度只要是20℃~35℃即可,而在本實驗中係於25℃進行發酵。 Fig. 8 is an experimental result comparing the production of SAMe and SA amino acid in a case where fermentation periods are different. The production of SAMe and SA amino acid measured after the completion of the aging was measured, and the most generated one was set to 100 and compared. Further, the fermentation temperature may be 20 ° C to 35 ° C, and in the present experiment, the fermentation is carried out at 25 ° C.

如圖8所示,相對於0.5個月而言,在1個月時SAMe及SA胺基酸的產生係增加,但在1.5個月時SAMe及SA胺基酸的產生係減少。 As shown in Fig. 8, the production of SAMe and SA amino acids increased at one month relative to 0.5 months, but the production of SAMe and SA amino acids decreased at 1.5 months.

從而,胎盤溶液之發酵期較佳係設為1個月。 Thus, the fermentation period of the placental solution is preferably set to one month.

其次,針對熟成步驟進行說明。 Next, the ripening step will be described.

圖9係對使熟成期不同之情況之SAMe及SA胺基酸的產生進行比較之實驗結果。測定在熟成結束後所測定之SAMe及SA胺基酸的產生,將產生最多者設為100並進行比較。另外,熟成溫度只要是20℃~25℃即可,而在 本實驗中係於25℃進行熟成。發酵期係設為1個月。 Fig. 9 is an experimental result comparing the production of SAMe and SA amino acid in a case where the ripening period is different. The production of SAMe and SA amino acid measured after the completion of the aging was measured, and the most generated one was set to 100 and compared. In addition, the ripening temperature may be 20 ° C to 25 ° C, but In this experiment, aging was carried out at 25 °C. The fermentation period is set to 1 month.

如圖9所示,相對於1.5個月而言,在2個月時SAMe及SA胺基酸的產生係增加,但在2.5個月時SAMe及SA胺基酸的產生係減少。 As shown in Fig. 9, the production of SAMe and SA amino acid increased at 2 months, but the production of SAMe and SA amino acid decreased at 2.5 months.

圖10係顯示依據本實施例之發酵熟成胎盤溶液的固形份之分子量分佈。將未經發酵熟成之胎盤溶液的固形份作為比較例。 Figure 10 is a graph showing the molecular weight distribution of the solid portion of the fermented mature placenta solution according to the present embodiment. The solid portion of the unfermented cooked placenta solution was used as a comparative example.

依據本實施例之發酵熟成胎盤溶液係使用相對於胎盤溶液而言以重量比計6%的黑糖而得者。此外,自經發酵熟成之胎盤溶液(胎盤素)去除水分而獲得粉末狀的固形份(胎盤素末)。 The fermented mature placental solution according to the present example was obtained by using 6% by weight of brown sugar with respect to the placental solution. Further, the fermented mature placenta solution (Placenta) was dehydrated to obtain a powdery solid fraction (placenta).

在熟成步驟之後所計測之分子量分佈,在依據本實施例之發酵熟成胎盤溶液的固形份中,若與未經發酵熟成之胎盤溶液的固形份進行比較,則於未滿200、1000~3000、3000~6000可見到明確的差異,就未滿200而言達10~20%、就1000~3000而言達30~40%、就3000~6000而言達20~25%。 The molecular weight distribution measured after the ripening step is compared with the solid portion of the fermented mature placenta solution according to the present embodiment, and is less than 200, 1000 to 3000, Between 3000 and 6000, a clear difference can be seen, which is 10 to 20% for less than 200, 30 to 40% for 1000 to 3000, and 20 to 25% for 3000 to 6000.

圖11係顯示依據本實施例之發酵熟成胎盤溶液的固形份之成分。將未經發酵熟成之胎盤溶液的固形份作為比較例。 Fig. 11 is a view showing the components of the solid portion of the fermented mature placenta solution according to the present embodiment. The solid portion of the unfermented cooked placenta solution was used as a comparative example.

在熟成步驟之後所計測之成分,在依據本實施例之發酵熟成胎盤溶液的固形份中,若與未經發酵熟成之胎盤溶液的固形份進行比較,則特定而言,丙胺酸及胱胺酸係大幅增加,包含丙胺酸10莫耳%以上、胱胺酸0.4莫耳%以 上。 The component measured after the ripening step, in the solid portion of the fermented mature placenta solution according to the present embodiment, is specifically compared with the solid portion of the unfermented cooked placental solution, specifically, alanine and cystine The system has increased substantially, including more than 10% of alanine and 0.4% of cystine. on.

此外,除此以外,以屬於必需胺基酸之離胺酸、組胺酸、纈胺酸、蘇胺酸、色胺酸為首,麩胺酸、絲胺酸、天冬醯胺、天冬胺酸等胺基酸在熟成步驟後係呈增加之傾向。 In addition, in addition to the essential amino acids of lysine, histidine, valine, threonine, tryptophan, glutamic acid, serine, aspartame, aspartame Amino acids such as acids tend to increase after the ripening step.

離胺酸係除了提高肝機能以外,尚作為抗體或激素、酵素等素材修復身體之組織。組胺酸係作用於關節,對慢性關節風濕症等之預防/改善發揮效果。纈胺酸係除了改善肝機能以外,尚增強身體之肌肉或恢復疲勞。此外,蘇胺酸亦會改善肝機能,並作為促進成長之營養素而發揮功能。色胺酸係作為腦內神經傳導物質,而具有使精神機能安定之效果。麩胺酸係大量包含在肝臟或豬肉中,藉由迅速地被身體所吸收而作為能量源。絲胺酸係包含在大豆等中,具有抑制肌膚的老化之效果。此外,天冬醯胺及天冬胺酸係除了將屬於有害物質之氨排出至體外,而保護中樞神經系統以外,尚具有促進能量代謝並促進疲勞恢復之效果。 In addition to improving liver function, the lysine-based system repairs the body as an antibody, hormone, or enzyme. Histamine acts on the joints and exerts effects on prevention/improvement of chronic joint rheumatism. In addition to improving liver function, proline acid enhances the body's muscles or restores fatigue. In addition, sulphate also improves liver function and functions as a nutrient for growth. The tryptophanic acid acts as a neurotransmitter in the brain and has an effect of calming the mental function. The glutamic acid is contained in large amounts in the liver or pork and is rapidly absorbed by the body as an energy source. The serine acid is contained in soybeans and the like, and has an effect of suppressing aging of the skin. In addition, aspartame and aspartate excrete ammonia, which is a harmful substance, and protect the central nervous system, thereby promoting energy metabolism and promoting fatigue recovery.

圖12係顯示依據本實施例之發酵熟成胎盤溶液的固形份之礦物質/維生素含量。將未經發酵熟成之胎盤溶液的固形份作為比較例。 Figure 12 is a graph showing the mineral/vitamin content of the solid portion of the fermented cooked placenta solution according to this example. The solid portion of the unfermented cooked placenta solution was used as a comparative example.

在熟成步驟之後所計測之成分,在依據本實施例之發酵熟成胎盤溶液的固形份中,若與未經發酵熟成之胎盤溶液的固形份進行比較,則特定而言,鈉、鈣、鎂、菸鹼酸、鋅、維生素B1、維生素B2、維生素B6係大幅增加, 包含鈉300mg/100g以上、鈣100mg/100g以上、鎂15mg/100g以上、菸鹼酸2mg/100g以上、鋅2mg/100g以上、維生素B1 0.1mg/100g以上、維生素B2 0.1mg/100g以上、維生素B6 0.05mg/100g以上。 The component measured after the ripening step, in the solid portion of the fermented mature placenta solution according to the present embodiment, is compared with the solid portion of the unfermented cooked placental solution, specifically, sodium, calcium, magnesium, Nicotinic acid, zinc, vitamin B 1 , vitamin B 2 and vitamin B 6 are greatly increased, including sodium 300 mg/100 g or more, calcium 100 mg/100 g or more, magnesium 15 mg/100 g or more, nicotinic acid 2 mg/100 g or more, and zinc 2 mg. /100g or more, vitamin B 1 0.1mg/100g or more, vitamin B 2 0.1mg/100g or more, and vitamin B 6 0.05mg/100g or more.

在SAMe之分析中,係使用薄層層析(TLC)及HPLC定量。 In the analysis of SAMe, it was quantified using thin layer chromatography (TLC) and HPLC.

在TLC之樣品調整中,係設為以1.5N鹽酸於室溫下萃取1小時。在展開溶媒中,係以4:1:2使用1-丁醇:醋酸:水,並以茚三酮顯色進行檢測。 In the sample conditioning of TLC, it was set to extract with 1.5 N hydrochloric acid at room temperature for 1 hour. In the developing solvent, 1-butanol:acetic acid:water was used at 4:1:2, and detection was carried out by ninhydrin color development.

HPLC定量係使用「GL Sciences股份有限公司GL-7400型」機器,並使用管柱(Kemco股份有限公司Chemcopak Nucleosil 100-10SA),移動相係依流速1.0mL/分鐘,以利用0.05M(NH4)2HPO4(pH 3.0)20分鐘,接著以5分鐘使組成變化成0.5M(NH4)2HPO4(pH 3.0)之線性梯度實行,並於260nm進行檢測。分析方法係依據後藤等人之方法(參考出處:「清酒醪中之S-腺苷甲硫胺酸的定量及變化」日本釀造協會誌,1992)。 For the HPLC quantification, the "GL Sciences Co., Ltd. GL-7400" machine was used, and a column (Kemco Chemcopak Nucleosil 100-10SA) was used, and the mobile phase was subjected to a flow rate of 1.0 mL/min to utilize 0.05 M (NH 4 ). 2 HPO 4 (pH 3.0) was carried out for 20 minutes, followed by a linear gradient of 0.5 M (NH 4 ) 2 HPO 4 (pH 3.0) in 5 minutes, and detection was carried out at 260 nm. The analysis method is based on the method of Goto et al. (refer to the source: "Quantification and change of S-adenosylmethionine in sake cellar", Japan Brewing Association, 1992).

在SA胺基酸之分析中係使用HPLC定量。 In the analysis of the SA amino acid, it was quantified using HPLC.

使用「GL Sciences股份有限公司GL-7400型」機器,並使用管柱(GL Sciences股份有限公司Inertsil ODS-4),移動相係依流速1.0mL/分鐘,以甲醇:0.1%H3PO4=2:98實行,並於214nm進行檢測。分析方法係依據GL Sciences股份有限公司之分析應用程式(Data.No.LB110-0919)。 The "GL Sciences Co., Ltd. GL-7400" machine was used, and a pipe column (GL Sciences Co., Ltd. Inertsil ODS-4) was used. The mobile phase was at a flow rate of 1.0 mL/min to methanol: 0.1% H 3 PO 4 = 2:98 was implemented and tested at 214 nm. The analytical method was based on the analytical application of GL Sciences, Inc. (Data. No. LB110-0919).

〔產業上之可利用性〕 [Industrial Applicability]

依據本發明之製造方法所製造之發酵熟成胎盤溶液係可利用為健康食品或化妝品用原料。 The fermented mature placenta solution produced by the production method of the present invention can be used as a raw material for health foods or cosmetics.

Claims (7)

一種發酵熟成胎盤溶液的製造方法,係在豬、羊或馬的胎盤溶液中,加入具有發酵作用之酵母菌而使前述胎盤發酵及熟成之發酵熟成胎盤溶液的製造方法,其特徵為將相對於前述胎盤溶液而言以重量比計6~15%的黑糖添加至前述胎盤溶液中並使其發酵,並在發酵後使其熟成。 A method for producing a fermented mature placenta solution, which is a method for producing a placenta solution by fermenting yeast and fermenting the aforementioned placenta by fermenting yeast in a placenta solution of pig, sheep or horse, which is characterized in that it is relative to In the above placental solution, 6 to 15% by weight of brown sugar is added to the above-mentioned placental solution, fermented, and matured after fermentation. 如請求項1之發酵熟成胎盤溶液的製造方法,其係具有下列步驟:將前述黑糖添加至前述胎盤溶液中之黑糖添加步驟;在前述黑糖添加步驟之後,於80~100℃的溫度中進行20分鐘~60分鐘加熱殺菌之殺菌步驟;在前述殺菌步驟之後,強制冷卻至35℃以下的溫度之冷卻步驟;在前述冷卻步驟之後,加入前述酵母菌並於20℃~35℃的溫度中使其發酵1個月之發酵步驟;以及在前述發酵步驟之後,於20℃~25℃的溫度中使其熟成2個月之熟成步驟。 A method for producing a fermented mature placenta solution according to claim 1, comprising the steps of: adding the brown sugar to the brown sugar adding step in the placental solution; and performing the brown sugar adding step at a temperature of 80 to 100 ° C. a sterilization step of heating sterilization in minutes to 60 minutes; a cooling step of forced cooling to a temperature below 35 ° C after the sterilization step; after the cooling step, the yeast is added and allowed to be heated at a temperature of 20 ° C to 35 ° C. The fermentation step of fermentation for one month; and the ripening step of aging at a temperature of 20 ° C to 25 ° C for 2 months after the aforementioned fermentation step. 如請求項2之發酵熟成胎盤溶液的製造方法,其中,在前述熟成結束後所測定之S-腺苷甲硫胺酸(SAMe)及超活性胺基酸(SA胺基酸)的濃度係將相對於前述胎盤溶液而言以重量比計10%的蔗糖代替前述黑糖添加至前述胎盤溶液中並施行前述殺菌步驟至前述熟成步驟所產生之SAMe及SA胺基酸的濃度以上。 The method for producing a fermented mature placenta solution according to claim 2, wherein the concentration of S-adenosylmethionine (SAMe) and superactive amino acid (SA amino acid) measured after completion of said ripening is To the above-mentioned placental solution, 10% by weight of sucrose is added to the above-mentioned placental solution instead of the above-mentioned brown sugar, and the above sterilization step is carried out to the above-mentioned concentration of SAMe and SA amino acid produced by the above-mentioned ripening step. 如請求項2之發酵熟成胎盤溶液的製造方法,其中,在前述熟成結束後所測定之SAMe及SA胺基酸的濃度係將相對於前述胎盤溶液而言以重量比計10%的葡萄糖代替前述黑糖添加至前述胎盤溶液中並施行前述殺菌步驟至前述熟成步驟所產生之SAMe及SA胺基酸的濃度以上。 The method for producing a fermented mature placenta solution according to claim 2, wherein the concentration of the SAMe and the SA amino acid measured after the completion of the aging is replaced by 10% by weight of glucose relative to the placental solution. Brown sugar is added to the aforementioned placental solution and subjected to the aforementioned sterilization step to a concentration of SAMe and SA amino acid produced by the aforementioned ripening step. 如請求項2至4中任一項之發酵熟成胎盤溶液的製造方法,其中,在前述熟成步驟之後的固形份中所計測之分子量分佈係就未滿200而言為10~20%、就1000~3000而言為30~40%、就3000~6000而言為20~25%。 The method for producing a fermented mature placenta solution according to any one of claims 2 to 4, wherein the molecular weight distribution measured in the solid portion after the ripening step is 10 to 20% less than 200, and is 1000. ~3000 is 30~40%, and 3000~6000 is 20~25%. 如請求項2至4中任一項之發酵熟成胎盤溶液的製造方法,其中,在前述熟成步驟之後的發酵熟成胎盤溶液的固形份中,係包含丙胺酸10莫耳%以上、胱胺酸0.4莫耳%以上。 The method for producing a fermented mature placenta solution according to any one of claims 2 to 4, wherein the solid portion of the fermented mature placenta solution after the ripening step comprises 10 mol% or more of alanine and cystine acid 0.4. More than Mole. 如請求項2至4中任一項之發酵熟成胎盤溶液的製造方法,其中,在前述熟成步驟之後的發酵熟成胎盤溶液的固形份中,係包含鈉300mg/100g以上、鈣100mg/100g以上、鎂15mg/100g以上、菸鹼酸2mg/100g以上、鋅2mg/100g以上。 The method for producing a fermented mature placenta solution according to any one of claims 2 to 4, wherein the solid portion of the fermented mature placenta solution after the ripening step comprises sodium 300 mg/100 g or more and calcium 100 mg/100 g or more. Magnesium 15mg/100g or more, nicotinic acid 2mg/100g or more, and zinc 2mg/100g or more.
TW104137012A 2015-03-11 2015-11-10 Manufacturing method of fermented matured placenta solution TWI633189B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015-048056 2015-03-11
JP2015048056A JP6282243B2 (en) 2015-03-11 2015-03-11 Method for producing fermentation-aged placenta solution

Publications (2)

Publication Number Publication Date
TW201632627A true TW201632627A (en) 2016-09-16
TWI633189B TWI633189B (en) 2018-08-21

Family

ID=56880421

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104137012A TWI633189B (en) 2015-03-11 2015-11-10 Manufacturing method of fermented matured placenta solution

Country Status (5)

Country Link
JP (1) JP6282243B2 (en)
KR (1) KR20170040311A (en)
CN (1) CN106488708B (en)
TW (1) TWI633189B (en)
WO (1) WO2016143357A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6213756B1 (en) * 2017-02-09 2017-10-18 有限会社ポークランド Method for producing placenta extract, method for producing placenta extract-containing powder, and method for producing processed food
JP6373444B1 (en) * 2017-05-10 2018-08-15 株式会社ホルス Amnion-derived raw material manufacturing method, cosmetic manufacturing method, and health food manufacturing method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4156507B2 (en) * 2003-12-26 2008-09-24 堯 近藤 Method for producing health food containing porcine placenta
KR101132392B1 (en) * 2009-08-14 2012-04-03 (주)청룡수산 Fermented Placenta Compositin and Use Thereof
CN102327291B (en) * 2011-07-12 2013-02-13 湖州康海斯生物科技有限公司 Stock solution of sheep embryo and sheep placental peptide and preparation method thereof

Also Published As

Publication number Publication date
JP2016167982A (en) 2016-09-23
CN106488708B (en) 2019-10-01
WO2016143357A1 (en) 2016-09-15
KR20170040311A (en) 2017-04-12
CN106488708A (en) 2017-03-08
TWI633189B (en) 2018-08-21
JP6282243B2 (en) 2018-02-21

Similar Documents

Publication Publication Date Title
RU2577699C2 (en) Collagen hydrolysate, applied for improving person's skin, hair and/or nail health
JP5653759B2 (en) Skin aging inhibitory peptide
JP6462101B2 (en) Collagen hydrolyzate and use thereof
KR101980361B1 (en) Collagen hydrolysate having high concentration of collagen tripeptide and uses thereof
JP2003137807A (en) Collagen-producing promoter, cosmetic, food and pharmaceutical containing the same and external preparation for preventing or improving dermatosis
KR20070003907A (en) Agents for sequestering serum aging factors and uses therefore
WO2006134685A1 (en) Hair care preparation
Alvares et al. Acute effect of fish protein hydrolysate supplementation on vascular function in healthy individuals
JP2007291062A (en) Compounding agent for base cosmetic, and base cosmetic
JP6877924B2 (en) Epidermal cell-cell function enhancer
TWI633189B (en) Manufacturing method of fermented matured placenta solution
JP2016193857A (en) Skin cosmetic, and food and drink
JP5250302B2 (en) Antihyperglycemic agent
KR20160037612A (en) Composition for improving skin moisturization comprising royal jelly
JP2008063315A (en) Compounding ingredient for makeup product and makeup product improving texture
JP4698935B2 (en) Skin collagen production promoter
US20080153741A1 (en) Compounding ingredients for cosmetic formulation for improving skinditch density and cosmetic
WO2006078067A1 (en) Age production inhibitor, use of the same, and process for production of the same
JP6666650B2 (en) Skin cosmetics, hair cosmetics and foods and drinks
JP4707401B2 (en) Antioxidant peptides from royal jelly
WO2009155097A1 (en) Natural product inhibitors of 3dg
JP7082827B2 (en) Cosmetics
JP2008260761A (en) Milk component hydrolyzate
JP2013221017A (en) Epidermal cell activator, cosmetic including the same, skin care external preparation and anti-wrinkle cosmetic
KR20070034212A (en) Health functional food for immune strengthening or antioxidant containing whey protein hydrolyzate as an active ingredient